| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |